SARS-CoV-2 Orf9b suppresses type I interferon responses by targeting TOM70He‐wei Jiang, Sheng‐ce Tao, Hong Chen et al.|Cellular and Molecular Immunology|2020Cited by 376
Nsp2 has the potential to be a drug target revealed by global identification of SARS-CoV-2 Nsp2-interacting proteinsYun-xiao Zheng, Sheng‐ce Tao, Wei-Sha Kong et al.|Acta Biochimica et Biophysica Sinica|2021Cited by 47